Results 11 to 20 of about 126,042 (242)
Molecular characteristics and metastasis predictor genes of triple-negative breast cancer: a clinical study of triple-negative breast carcinomas. [PDF]
PLoS ONE, 2012 BackgroundTriple-negative breast cancer is a subtype of breast cancer with aggressive tumor behavior and distinct disease etiology. Due to the lack of an effective targeted medicine, treatment options for triple-negative breast cancer are few and ...
Wen-Hung Kuo +6 more
doaj +1 more source
Immune Effect of Active Components of Traditional Chinese Medicine on Triple-Negative Breast Cancer
Frontiers in Pharmacology, 2021 Triple-negative breast cancers are heterogeneous, poorly prognostic, and metastatic malignancies that result in a high risk of death for patients. Targeted therapy for triple-negative breast cancer has been extremely challenging due to the lack of ...
Wenjie Zhao +8 more
doaj +1 more source
World Journal of Surgical Oncology, 2020 Background Metaplastic breast cancer remains poorly characterized given its rarity and heterogeneity. The majority of metaplastic breast cancers demonstrate a phenotype of triple-negative breast cancer; however, differences in clinical outcomes between ...
Evan Morgan +18 more
doaj +1 more source
Research progress of single-cell sequencing in neoadjuvant chemotherapy for triple-negative breast cancer [PDF]
Zhongguo aizheng zazhi, 2021 Triple-negative breast cancer is the most invasive and malignant type of breast cancer. At present, therapy for triple-negative breast cancer is the comprehensive treatment regimens based on chemotherapy, in which neoadjuvant chemotherapy plays an ...
HU Xi’e , YANG Zhenyu , XUE Jingyi , YANG Ping , PENG Shujia , YUAN Lijuan , BAO Guoqiang
doaj +1 more source
miR-331-3p Suppresses Cell Proliferation in TNBC Cells by Downregulating NRP2
Technology in Cancer Research & Treatment, 2020 Purpose: Triple-negative breast cancer is characterized by fast progression with high possible for metastasis and poor survival. Dysfunction of microRNAs plays an important role in the initiation and progression of cancer.
Mingchuan Zhao PhD +5 more
doaj +1 more source
Technology in Cancer Research & Treatment, 2020 Background: Triple-negative breast cancer encompasses heterogeneous subtypes. Neoadjuvant chemotherapy is ineffective against some triple-negative breast cancers, while others show a favorable prognosis despite chemoresistance.
Koichi Kubouchi MD +3 more
doaj +1 more source
MicroRNAs expression in triple negative vs non triple negative breast cancer in Tunisia: interaction with clinical outcome. [PDF]
PLoS ONE, 2014 MicroRNAs are small, non coding regulatory molecules containing approximately 21 to 25 nucleotides. They function as controllers of expression at post transcriptional levels of most human protein-coding genes and play an essential role in cell signaling ...
Imen Medimegh +10 more
doaj +1 more source
Treatment of thrice-negative breast cancer in a patient with metabolic syndrome
Исследования и практика в медицине, 2021 Breast cancer (BC) remains one of the most common diseases of the female population. According to statistics, breast cancer is detected in every eighth woman. Approximately 20‑24% of breast cancer patients are diagnosed with triple negative breast cancer.
G. E. Roitberg +2 more
doaj +1 more source
Technology in Cancer Research & Treatment, 2021 Triple-negative breast cancer is a heterogeneous disease with different molecular and histological subtypes. The Androgen receptor is expressed in a portion of triple-negative breast cancer cases and the activation of the androgen receptor pathway is ...
Taobo Hu +3 more
doaj +1 more source
Frontiers in Oncology, 2023 Triple-negative breast cancer refers to breast cancer patients with negative estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor (HER2).
Ruoyan Qin +6 more
doaj +1 more source